Artal Group S.a.

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 2Value: $884.2MLatest: 2025Q1

Artal Group S.A. is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 2 holdings worth $0.9 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "LXRX",
  "CAVA"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 2
Total Value: 884228437
Accession Number: 0001053906-25-000010
Form Type: 13F-HR
CIK: artal-group-sa
Manager Name: Artal-Group-Sa

Data Enrichment

100% identified

2 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

2 positions • $884,228.437K total value

2 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Sort by:

CAVA GROUP, INC.

CAVA|148929102

Shares:9.5M

Value:$821.6M

LEXICON PHARMACEUTICALS, INC.

LXRX|528872302

Shares:136.2M

Value:$62.6M

Instrument	Shares		Other Manager	Value
CAVA GROUP, INC.(CAVAcusip148929102)	9.5M	QoQ 0.00% (-0) YoY -64.13% (-17.0M)	All Managers (Combined)	$821.6M	QoQ -23.39% (-$250.9M) YoY -55.75% (-$1035.3M)
LEXICON PHARMACEUTICALS, INC.(LXRXcusip528872302)	136.2M	QoQ 0.00% (-0) YoY +19.41% (-22.1M)	All Managers (Combined)	$62.6M	QoQ -37.83% (-$38.1M) YoY -77.11% (-$211.0M)